NEW YORK, Feb. 26, 2018 -- Chartis Research has named Hanweck as a RiskTech Quadrant® “Best-of-breed” solution for Hedge Fund Risk Management Technology. Chartis is an independent research and advisory firm that provides technology and business advice to the global financial risk management industry.
Hanweck was recognized in Chartis’ latest research report, Hedge Fund Risk Management Technology 2018. The research highlights several important trends in the approximately $9 billion market for hedge fund risk, analytics, and trading technology. For example, Chartis finds that hedge funds are turning more frequently toward third-party, risk-as-a-service (RaaS) technology and employing specific, tailored risk solutions to integrate into their overall risk technology architecture.
Sidhartha Dash, Research Director at Chartis Research, said, “The hedge fund community is a diverse group of players with a wide range of risk management requirements and technology infrastructures. In addressing this sizable market, Hanweck has developed a solution that can be integrated into either a fund’s existing internally developed risktech architecture or a comprehensive, multiple-vendor solution.”
“As referenced in the Chartis report, hedge funds today require real-time risk management,” said Gerald A. Hanweck Jr., PhD, CEO of Hanweck. “Our analytic solutions provide real-time risk analytics at either the individual security level or on an aggregate portfolio basis, making our offering a flexible element to integrate within a fund’s overall risk framework.”
For more information about the report, please visit www.chartis-research.com or www.risktech-forum.com.
About Chartis
Chartis Research is the leading provider of research and analysis on the global market for risk technology. It is part of Infopro Digital, which owns market-leading brands such as Risk and Waters Technology. Chartis's goal is to support enterprises as they drive business performance through improved risk management, corporate governance and compliance, and to help clients make informed technology and business decisions by providing in-depth analysis and actionable advice on virtually all aspects of risk technology. The RiskTech Quadrant® has a sophisticated ranking methodology to explain which solutions would be best for buyers, depending on their implementation strategies. RiskTech Quadrant®, RiskTech100® and FinTech Quadrant™ are registered trademarks of Chartis Research. www.chartis-research.com
About Hanweck
Hanweck is the leading provider of real-time risk analytics on global derivatives markets focusing on the large-scale risk problems of banks, broker/dealers, hedge funds, central counterparties and exchanges -- where the number of instruments and positions number in the millions. Hanweck delivers its risk analytics as a real-time service -- usually in the form of a data feed -- dramatically simplifying integration with its customers' risk architecture. Hanweck's institutional investors include Nasdaq and Argentum, a New York-based private equity firm. For more information, please visit www.hanweck.com or follow Hanweck on Twitter and LinkedIn.
Contact Information Media/Marketing: Molly McGregor, [email protected] Sales/Business Development: [email protected]


Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring 



